Risk factors for diabetes type-2 and cardiovascular disease among Somalis in Somaliland
The main objective of this study is to assess the prevalence of risk factors for diabetes and cardiovascular disease in Somalia. According to the WHO, diabetes and cardiovascular diseases (CVDs) are the leading causes of death and disability worldwide. An estimated 17.5 million people died from CVDs in 2012, representing 31% of all global deaths. Over three quarters of CVD deaths take place in low and middle income countries. However, we do not have sufficient knowledge about the prevalence of risk factors for diabetes and CVDs among Somaliland population. The proposed project is a cross-sectional study. Participants will comprise 1100 adults, aged 20-69 year, living in Hargeisa city. For the purpose of the project, the following information will be collected: • Background information such as gender, age, education, occupation, self-reported illness, family history of diabetes and CVDs and use of medications will be collected using a questionnaire. Information about dietary habits will be collected using a food frequency questionnaire (FFQ). • Behavioral measurements such as smoking, alcohol, physical activity will be collected with same questionnaire. • Physical measurements: Height, weight, waist and hip circumference. • Blood pressure measurements: Three times measurements with one minute interval. • Blood samples: blood samples will be collected from participants to determine the concentrations of HbA1c, serum glucose and lipids (total cholesterol, HDL, LDL and glycerides) in blood. All the obtained material, including questionnaires and consent letters, will be kept at the University of Hargeisa during the time of data collection. The material will, following completion of the data collection, be transferred to HELSAM at the University of Oslo. Blood samples will be stored in a new, project specific biobank until the time of analysis, “Risk factors for diabetes and cardiovascular disease in Somaliland” at the University of Oslo with Ahmed Madar in charge of the biobank.
Prosjektbeskrivelse med vedlegg